EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Safety of OnabotulinumtoxinA (OnabotA) During Pregnancy and Breastfeeding: Implications for Chronic Migraines

Sondos Eladawi iD, Prut Koonalintip iD, Amelia Ngomuo, Emily Leech, Mark Thaller iD, Benjamin R Wakerley

Life · 24.07.2026 · 16 (8) · 1228

DOI: 10.3390/life16081228 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 24.07.2026. Verfasst von Sondos Eladawi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmin…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: A migraine is a highly prevalent and disabling neurological disorder that mainly affects women of childbearing age. Treatment options for migraine prevention are limited during pregnancy and breastfeeding. Although OnabotulinumtoxinA (OnabotA) has proven efficacy and safety in chronic migraine prophylaxis in adults, its safety in pregnancy and breastfeeding remains understudied.

Methods

Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology, this review systematically appraised the evidence on the use of OnabotA for chronic migraines and other neurological conditions during pregnancy and breastfeeding across four electronic databases between January 2000 and December 2025.

Results

In summary, of the 555 OnabotA-exposed pregnancies, 80.2% resulted in full-term births, with a 17.5% loss rate (73 spontaneous, 21 elective, three unspecified) and 1.6% reporting foetal anomalies. These findings align with general population baselines for miscarriages (12.5–18.7%) and foetal anomalies (3–5%), respectively. Among 94 cases of reported breastfeeding, no adverse infant events or developmental delays were observed at 1 year. Maternal outcomes showed favourable symptom control without adverse effects.

Conclusions

Although there is limited data on the use of OnabotA in pregnancy and breastfeeding, no significant adverse effects have been identified in pregnant mothers or neonates. OnabotA should therefore be considered on a case-by-case basis for treatment of various neurological conditions, including migraines, when there are no better safe alternatives.

Schlagwörter

Stichwörter der Autor:innen

OnabotulinumtoxinAchronic migrainesdystoniapregnancy

Autor:innen und Institutionen

  • Department of Neurology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2GW, UK.
  • Division of Neurology, Department of Internal Medicine, Prince of Songkla University, Hatyai 90110, Songkhla, Thailand.
  • Birmingham Medical School, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Institute of Metabolism and Systems Research, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Department of Neurology, Sandwell and West Birmingham NHS Trust, West Bromwich B71 4HJ, UK.

ORCID-Profile: Sondos Eladawi, Prut Koonalintip, Mark Thaller

Zitieren

APA

Eladawi, S., Koonalintip, P., Ngomuo, A., Leech, E., Thaller, M., & Wakerley, B. R. (2026). The Safety of OnabotulinumtoxinA (OnabotA) During Pregnancy and Breastfeeding: Implications for Chronic Migraines. Life, 16(8), 1228. https://doi.org/10.3390/life16081228

Vancouver

Eladawi S, Koonalintip P, Ngomuo A, Leech E, Thaller M, Wakerley BR. The Safety of OnabotulinumtoxinA (OnabotA) During Pregnancy and Breastfeeding: Implications for Chronic Migraines. Life. 2026;16(8):1228. doi:10.3390/life16081228

BibTeX
@article{Eladawi2026,
  author = {Eladawi, Sondos and Koonalintip, Prut and Ngomuo, Amelia and Leech, Emily and Thaller, Mark and Wakerley, Benjamin R},
  title = {The Safety of OnabotulinumtoxinA (OnabotA) During Pregnancy and Breastfeeding: Implications for Chronic Migraines},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1228},
  doi = {10.3390/life16081228}
}
Kostenlos starten →